For instance, ER+ BCs exhibit overexpression of KDM4A and KDM4B; the two enzymes promote cancer growth and metastasis by targeting either the Notch1-NICD-dependent signaling (for KDM4A) or the estrogen signaling (for KDM4B) pathways [141,142]. The gene discussed is KDM4A; the disease is cancer.